Autologous neural stem cells / Theratechnologies - LARVOL DELTA

Transplantation of Neural Stem Cell-Derived Neurons for Parkinson's Disease (clinicaltrials.gov) - P1/2 | N=0 | Withdrawn | Sponsor: NeuroGeneration | N=12 ➔ 0 | Trial completion date: Jun 2023 ➔ Jun 2024 | Not yet recruiting ➔ Withdrawn | Trial primary completion date: Dec 2022 ➔ Dec 2023

Enrollment change • Trial completion date • Trial primary completion date • Trial withdrawal • CNS Disorders • Movement Disorders • Parkinson's Disease • Solid Tumor • Transplantation

Molecular Analysis of Human Neural Stem Cells (clinicaltrials.gov) - P=N/A; N=20; Enrolling by invitation; Sponsor: NeuroGeneration; Trial completion date: Dec 2021 ➔ Dec 2023; Trial primary completion date: Dec 2020 ➔ Dec 2022

Biomarker • Clinical • Trial completion date • Trial primary completion date • CNS Disorders • Gene Therapies • Movement Disorders • Parkinson's Disease